Fusion announces first patient dosed in Phase 2 portion of AlphaBreak trial
PremiumThe FlyFusion announces first patient dosed in Phase 2 portion of AlphaBreak trial
6M ago
Fusion Pharmaceuticals Inc. Grapples with Tax Uncertainty: Potential Impacts on Finances and Investor Trust
Premium
Company Announcements
Fusion Pharmaceuticals Inc. Grapples with Tax Uncertainty: Potential Impacts on Finances and Investor Trust
6M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
6M ago
Fusion Pharmaceuticals downgraded to Hold from Buy at TD Cowen
PremiumThe FlyFusion Pharmaceuticals downgraded to Hold from Buy at TD Cowen
7M ago
Fusion Pharmaceuticals management to meet with Oppenheimer
Premium
The Fly
Fusion Pharmaceuticals management to meet with Oppenheimer
7M ago
Fusion announces presentation of data from Phase 2 TATCIST clinical trial
Premium
The Fly
Fusion announces presentation of data from Phase 2 TATCIST clinical trial
7M ago
Wells Fargo downgraded, Best Buy upgraded: Wall Street’s top analyst calls
PremiumThe FlyWells Fargo downgraded, Best Buy upgraded: Wall Street’s top analyst calls
8M ago
Fusion Pharmaceuticals downgraded to Neutral from Buy at B. Riley
Premium
The Fly
Fusion Pharmaceuticals downgraded to Neutral from Buy at B. Riley
8M ago
Fusion Pharmaceuticals downgraded to Market Perform from Strong Buy at Raymond James
Premium
The Fly
Fusion Pharmaceuticals downgraded to Market Perform from Strong Buy at Raymond James
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100